Making diagnostic imaging possible for patients with cardiac implants

March 19, 2014 by Shantell Kirkendoll
Making diagnostic imaging possible for patients with cardiac implants
Dr. Eric D. Good, left, implants ICD at University of Michigan Cardiovascular Center.

The University of Michigan Frankel Cardiovascular Center is on the forefront of making diagnostic imaging possible for patients with cardiac implants.

Electrophysiologist Eric D. Good, D.O., has implanted the state's first patient with BIOTRONIK's Iforia heart device. It's the only implantable cardioverter-defibrillator (ICD) approved for investigational use in (MRI).

The device is commercially available, but is in the newest phase of the ongoing ProMRI trial, a study that will examine ProMRI technology in the MRI environment.

"This technology is intended to allow full diagnostic capabilities for our who are likely to benefit from MRI scans," says Good.  "We are very excited to be participating in the ProMRI trial."

Every year, more than 300,000 people are implanted with ICD systems to regulate their heartbeat, and studies estimate that 50 percent to 75 percent will need an MRI scan in their lifetime.

MRI scans often provide diagnostic capabilities for certain diseases or conditions that cannot be adequately examined by x-ray, computerized tomography (CT) or ultrasound.

The strong magnetic forces applied during MRIs can potentially have a negative effect on both the device and leads, and are usually not recommended for pacemaker and ICD patients.

"MRI is a safe and reliable diagnostic technology, and demand for imaging studies is growing," says Theofanie Mela, M.D., director of Pacer and ICD Clinic at Massachusetts General Hospital in Boston. "ICD patients are frequently recommended for MRI scans, but until now they have been unable to receive them."

The ICD ProMRI with exclusion zone study is designed to confirm the safety and efficacy of BIOTRONIK's Iforia ICD during an MRI scan. All the devices in the study are conditionally approved by the U.S. Food and Drug Administration for use in the study, but still await FDA approval for use in the MRI environment.

Aside from featuring ProMRItechnology, the single chamber Iforia series is one of the smallest ICDs in the world and also offers more than 11 years longevity. This allows for a low replacement rate—a benefit for both patients and the health care system.

The latest phase of the ProMRI clinical study will recruit and evaluate 172 patients at 35 U.S. investigational centers, including the University of Michigan Cardiovascular Center.

The U-M's Heart Rhythm Program focuses on the diagnosis and treatment of all types of arrhythmias, or abnormal heart rhythms, including atrial fibrillation and flutter, sick sinus syndrome, sinus tachycardia, sinus bradycardia, ventricular tachycardia and genetic arrhythmia syndromes such as prolonged QT syndrome.

Explore further: MRI-friendly defibrillator implant opens doors for thousands of cardiac patients currently denied MRIs

Related Stories

MRI-friendly defibrillator implant opens doors for thousands of cardiac patients currently denied MRIs

January 29, 2013
Every year an estimated 1.5 million magnetic resonance imaging (MRI) scans are performed in Canada and the number is growing at a rate of about 10 per cent per year. At the same time, a soaring number of Canadians who rely ...

Magnetic resonance imaging with side effects

April 30, 2012
Great care should be taken when performing magnetic resonance imaging (MRI) in patients with a cardiac pacemaker. Henning Bovenschulte and his co-authors review recent findings in the latest issue of Deutsches Ärzteblatt ...

New implanted defibrillator works well without touching heart

August 26, 2013
A new type of defibrillator implanted under the skin can detect dangerously abnormal heart rhythms and deliver shocks to restore a normal heartbeat without wires touching the heart, according to research in the American Heart ...

First FDA approved subcutaneous implantable defibrillator available for patients

October 25, 2012
Sudden cardiac arrest (SCA) is a condition in which the heart suddenly stops pumping blood. When this occurs, blood stops flowing to the brain and other major organs. Recent estimates show that approximately 850,000 people ...

Elderly benefit from using implantable defibrillators

June 17, 2013
The elderly may benefit from implantable cardioverter defibrillators as much as younger people, according to new research in the American Heart Association journal Circulation.

Recommended for you

Five vascular diseases linked to one common genetic variant

July 27, 2017
Genome-wide association studies have implicated a common genetic variant in chromosome 6p24 in coronary artery disease, as well as four other vascular diseases: migraine headache, cervical artery dissection, fibromuscular ...

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.